The Path to Evidence-Based AIT: A guideline-driven and regulatory approach

This time, we are thrilled to welcome Prof. Oliver Pfaar (MD), a renowned allergist and immunologist, as our distinguished guest speaker.

In this session, Prof. Pfaar will explore "The Path to Evidence-Based AIT: A Guideline-Driven and Regulatory Approach". He will examine how the evidence base for allergen immunotherapy has evolved and gained increasing importance within the allergological community over recent years. Prof. Pfaar will also highlight the pivotal roles that pharmaceutical companies, regulatory authorities, and professional societies have played in advancing this field.

Following a comprehensive keynote presentation, you'll have the opportunity to engage directly with Prof. Pfaar. Whether you have practical, scientific, or career-related questions, this is your chance to gain valuable insights from an expert at the forefront of evidence-based allergy care.

Our dynamic moderators, Prof. Ann-Marie Schoos (Denmark) and Sebastian Seurig (Germany), will guide the session with their signature blend of professionalism and curiosity, ensuring a lively and interactive discussion.

Already have a question for Prof. Pfaar? Send it to us in advance at fascination-allergology@alk.net.

Quick Overview:
Guest Speaker: Prof. Oliver Pfaar (MD)
Topic: The Path to Evidence-Based AIT: A guideline-driven and regulatory approach
Moderation: Prof. Ann-Marie Schoos (MD), Dr. Julia Kurz (MD)